Skip to main content

Table 2 Multivariate regression analysis of the peripheral blood pressure with risk of endobronchial biopsy-induced hemorrhage

From: Association between blood pressure and the risk of biopsy-induced endobronchial hemorrhage during bronchoscopy

Components of blood pressure (mmHg)

n

Odds ratio (95% CI)

Non-adjusted

Adjusted

Systolic blood pressure

 Q1 (82-117)

159

1.0

1.0

 Q2 (118-130)

159

0.688 (0.437, 1.084)

0.710 (0.435, 1.158)

 Q3 (131-144)

164

0.772 (0.494, 1.207)

0.814 (0.493, 1.345)

 Q4 (145-195)

161

0.816 (0.522, 1.277)

0.806 (0.482, 1.347)

 P for trend

 

0.460

0.500

 Continuous, per 10 mmHg

 

0.994 (0.986, 1.002)

0.993 (0.984, 1.002)

Diastolic blood pressure

 Q1 (41-69)

154

1.0

1.0

 Q2 (70-77)

164

0.932 (0.589, 1.476)

1.019 (0.622, 1.670)

 Q3 (78-86)

162

1.029 (0.651, 1.627)

0.990 (0.600, 1.636)

 Q4 (87-114)

163

1.317 (0.839, 2.069)

1.452 (0.870, 2.426)

 P for trend

 

0.179

0.156

 Continuous, per 10 mmHg

 

1.007 (0.993, 1.020)

1.007 (0.991, 1.022)

Mean arterial pressure

 Q1 (59-87)

158

1.0

1.0

 Q2 (88-95)

161

0.785 (0.500, 1.232)

0.870 (0.536, 1.412)

 Q3 (96-104)

161

0.703 (0.446, 1.109)

0.697 (0.423, 1.150)

 Q4 (104-138)

163

0.925 (0.592, 1.443)

0.895 (0.540, 1.485)

 P for trend

 

0.690

0.553

 Continuous, per 10 mmHg

 

0.999 (0.987, 1.012)

0.998 (0.984, 1.012)

  1. *Adjusted for age, gender, BMI, smoking, lesion locations, cancer histological type and stage, PT, APTT, triglycerides, HDL-C, WBC, platelets, and CRP
  2. BMI, body mass index; PT, prothrombin time; APTT, activated partial thromboplastin time; HDL-C, high-density lipoprotein cholesterol; WBC, white blood cell; CRP, C-reactive protein